Compare ALLO & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | BRT |
|---|---|---|
| Founded | 2017 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 285.9M |
| IPO Year | 2018 | N/A |
| Metric | ALLO | BRT |
|---|---|---|
| Price | $1.69 | $14.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 2 |
| Target Price | $8.27 | ★ $19.75 |
| AVG Volume (30 Days) | ★ 7.1M | 35.4K |
| Earning Date | 03-12-2026 | 03-11-2026 |
| Dividend Yield | N/A | ★ 6.77% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $98,001,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.72 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.30 |
| 52 Week Low | $0.86 | $14.00 |
| 52 Week High | $3.78 | $19.01 |
| Indicator | ALLO | BRT |
|---|---|---|
| Relative Strength Index (RSI) | 52.72 | 47.15 |
| Support Level | $1.62 | $14.51 |
| Resistance Level | $1.97 | $14.81 |
| Average True Range (ATR) | 0.16 | 0.29 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 42.72 | 38.45 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.